Cancer Risks: Are We Getting Them Right?
Researching cancer mortality over the past few months has proved to be a bit of an eye-opener, and in three ways: firstly the level of excess mortality seen in a number of cancers, secondly the duration over which an extra risk persists, and thirdly that excess mortality may extend over a considerable period.
Risk Assessment of Non-Metastatic Breast Cancer in the Genomic Era
Underwriting breast cancer in 2017 will require an understanding of the current and growing role of genomics in the assessment of its mortality risk. This is not to lessen the importance of well-known prognosticators such as tumor/node/metastasis (TNM) staging, estrogen receptor/progesterone receptor (ER/PR) and human epidermal receptor growth factor 2 (HER2) receptor status, grade, or the mitotic activity index (MAI). Rather, it is to keep abreast of additional genomics-based prognostic tools that can be used to further stratify breast cancer and its risks.
Wearables in Life Insurance – Game Changer or Passing Fad?
Some life insurers now use data from fitness trackers to lower premiums. But does a policyholder’s number of steps really improve his or her mortality? Despite the link between a sedentary life and the risk of heart disease or cancer being well known, there is no consensus on how many daily steps reduce this risk.
Study Shows Link between Debt and Mortality Rates
A new study from the University of Colorado Denver shows a direct link between financial strain and increased risk of death, a finding with potentially major implications for both economic and health care policy.
Mortality Trends with Alzheimer’s Disease (Slides)
Slides from Dr. Brian Ivanovic’s presentation at the SOA Underwriting Issues & Innovations Seminar, Aug 1-2, 2016 in Chicago have been posted.
(Go to “Medical Topics” at the 8:05-9:40am time slot to download PDF)
Impaired Risk Review: Pancreatic Cancer: Still a Killer
Much progress has been made in combating cancer, but pancreatic cancer still sticks its ruthless head up as an actually increasing and an equally deadly one. In 2016, The American Cancer Society estimates almost 55,000 new diagnoses of pancreatic cancer will be made and 42,000 deaths will ensue.
Mortality Rates are Rising for White Middle-Aged Americans
White, middle-aged Americans are dying at rising rate according to a recently published report in the Proceedings of the National Academy of Sciences. The trend, which commenced in 1999, is not demonstrated in any other economically well develop country. Nor is it demonstrated in black and Hispanic Americans.
Diabetes Increases Mortality Risk After Acute Myocardial Infarction
Patients with diabetes are much more likely to die after an acute myocardial infarction (AMI) than patients without diabetes, according to a study published online June 15 in the Journal of Epidemiology and Community Health.
HIV and Hepatitis C and B Coinfetions
Around 36 million people are living with HIV in the world today (LVWH). 5 million of them are also infected with the hepatitis C virus (HCV) and 4 million with hepatitis B virus (HBV). In both cases, HIV and the immunodeficiency it causes, accelerate the progression of hepatitis B or C, inducing increased morbidity and mortality for all three infections.